Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total...

31
Vincent Varghese, DO, FACC, FSCAI Director, Interventional Cardiology Fellowship Program Deborah Heart & Lung Center Browns Mills, NJ Coronary Chronic Total Occlusions: When, How and Why to Intervene

Transcript of Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total...

Page 1: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Vincent Varghese, DO, FACC, FSCAI Director, Interventional Cardiology Fellowship Program

Deborah Heart & Lung Center Browns Mills, NJ

Coronary Chronic Total Occlusions: When, How and Why to Intervene

Page 2: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

2

No relevant financial disclosures related to this discussion

Page 3: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

What is a CTO ?

Clinical Definition – Coronary CTOs are commonly encountered complex lesions defined as > 99% blockage for 3 months or more, and are responsible for a clinically significant decrease in blood flow (TIMI 0-1).

Practical Definition – Any fully occluded artery that the interventionalist can’t immediately cross with a workhorse wire

Page 4: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Example

Page 5: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Myths of Chronic Total Occlusions

CTO’s are a rare finding CTO’s rarely cause ischemia due to robust collaterals Medical therapy is fine CTO’s do not affect mortality CTO’s have a poor success rate

Page 6: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Myth #1

CTO’s are rare

Page 7: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Chronic Total Occlusions

▪ NHLBI Dynamic Registry and BARI study 1997-1999 ▪ n=1,761

▪ Presence of a total occlusion 31% ▪ Attempted total occlusion 7.5%

Srinivas et al. Circulation 2002

Page 8: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

CTO Canadian Registry

CTO’s identified in 1,697 (18.4%) patients with significant CAD

Page 9: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Myth #2

CTO’s rarely cause ischemia

Page 10: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;
Page 11: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Collaterals are usually not sufficient to significantly reduce ischemia in CTO

Werner GS et al. European Heart Journal 2006

Page 12: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Effectiveness of Recanalization of CTO: A systematic review and meta-analysis

Effect on Angina55% reduction in anginal symptoms

Joyal D et al. Am Heart J 2010; 160: 179-87.

Page 13: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

64 year old female DM, HTN, Dyslipidemia S/P PCI DES LAD 2007 Coronary angiography for CCS class 3 angina LAD stent is patent….

Page 14: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

How would you treat this?

Page 15: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Now, how would you treat this?

Page 16: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Angioplasty Bypass Medical

Presence of a CTO influences treatment choices

With Occlusion (n=220) Without Occlusion (n=357)

Delacretaz et al, 1997

Page 17: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Presence of a CTO influences treatment choices

Christofferson et al, AJC, 2005, 1088-91 and Grantham et al. JACC: 2009

BARI Registry Substudy

%

PCICABGMed Rx

11

40

49

36

28

25

Page 18: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Myth #3

CTOs don’t affect mortality

Page 19: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

CTO PCI Success on MI rates

Joyal D et al. Am Heart J 2010; 160: 179-87.

Page 20: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

CTO PCI Success on mortality

Joyal D et al. Am Heart J 2010; 160: 179-87.

Page 21: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Concept of “double jeopardy”

Page 22: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

CTO impact on (Non-CTO vessel) AMI mortality Concept of “double jeopardy”

Van der Schaaf RJ et al. Am J Cardiology 2006; 98: 1165

Mortality in 1,417 patients treated for STEMI with PCI

Page 23: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

0

25

50

75

100

Suero Kitano Hoye Prasad Aziz Butler

92.097.0

78.0

93.590.0

73.083.0

93.0

71.0

88.080.0

65.0

Success Failure

CTO Treatment and Improved Long-term Survival (all p <.05)

(10 y) (8 y) (8 y) (10 y) (2 y) (6 y)

Hoye et al. EHJ 2005

Page 24: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Myth #4

CTO’s have a poor success rate

Page 25: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;
Page 26: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Meta-analysis of 18,061 patients from 65 studies

Page 27: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Success with the Hybrid Approach

Page 28: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

The Hybrid Algorithm for CTO PCIprovisional approaches

Dual Catheter Angiography

1. Clear proximal cap 2. Good Distal Target

3. Length < 20mm

Antegrade Retrograde

yes no

Wire escalation

Dissection Reentry (Crossboss-Stingray)

Wire escalation

Dissection Reentry (reverse CART)

yes yes nono

Dissection Reentry (reverse CART)

Dissection Reentry (Crossboss-Stingray))

fail

fail

fail

fail

Page 29: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Hybrid Algorithm Angiographic Considerations

1. Proximal Cap Geometry • Clear starting point • Ambiguous/confusing • Flush Occlusion / Poor Guide Support

2. Occlusion Length • Always do Bilateral Injections • < 20mm – higher likelihood of successful guide wire

crossing • > 20 mm – lower likelihood guidewire success, higher

likelihood of entering the subintimal space

3. Distal Landing Zone • Important branch/bifurcation at distal cap • Highly diseased distal vessel

4. Presence of Interventional Collaterals • Is retrograde possible?

Page 30: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Tool Box for CTO PCI

▪ Sheaths ▪ Guiding catheters ▪ Guide wires ▪ Microcatheters ▪ Snares and

externalization wires ▪ Complication

management

30

Page 31: Coronary Chronic Total Occlusions: When, How and … Varghese/CTO PPT.pdf · Coronary Chronic Total Occlusions: When, How and Why to Intervene . 2 ... Joyal D et al. Am Heart J 2010;

Conclusions

1. CTO’s are not infrequent (15-30%)

2. Opening CTO’s reduce angina, collaterals insufficient.

3. Interventional Cardiologists often don’t attempt CTO (15%), but they do refer for surgery.

4. Although CTO’s likely do not cause STEMI, the presence of a CTO increases mortality during future events (NSTEMI)

5. High success rates can be achieved, with low complications, using Hybrid algorithm